ArticleWorld journal of clinical cases2022
Biologic therapy for Crohn's disease over the last 3 decades.
Article in World journal of clinical cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 3 syntheses or guidelines pooled it, 7 citations in OpenAlex.
- Global Research Trends and Collaborative Networks in Cellular Therapy for Crohn's Disease: A Systematic Review and Bibliographic Analysis.Advances in experimental medicine and biology · 2025Pooled it
- Global Research Trends and Collaborative Networks in Cellular Therapy for Crohn's Disease: A Systematic Review and Bibliographic Analysis.Advances in experimental medicine and biology · 2025Pooled it
- Worldwide research trends in Crohn's disease treatment over the past 2 decades: a bibliometric analysis.Frontiers in pharmacology · 2024Pooled it
- Gut microbiota and autism spectrum disorders: where do we stand?Gut pathogens · 2023Article
- Global research trends on diet and nutrition in Crohn's disease.World journal of gastroenterology · 2023Article
- Research trends in the field of the gut-brain interaction: Functional dyspepsia in the spotlight - An integrated bibliometric and science mapping approach.Frontiers in neuroscience · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite the overload of publications on Crohn's disease (CD), no comprehensive analysis of biologic therapy for CD has been reported.
aimTo determine knowledge gaps and identify areas of interest of biologic therapy for CD.
methodsThe top 100 highest-cited original articles were identified from January 1991 to December 2020 in the Clarivate Analytics Web of Science Core Collection database. We conducted a bibliometric analysis of biologic therapy for CD based on total citations, summarized the bibliographic information of the articles related to CD biologic therapy, and explored the research hotspots.
resultsThe top 100 highest-cited original articles were identified with total citations ranging from 307 to 2978. The 2000s (Period II,
conclusionThe bibliometric analysis emphasized the key contributions to the development of the specialized field. These data would provide useful research insights into biologic therapy for CD for clinicians and researchers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.